Astellas Institute for Regenerative Medicine v. ImStem Biotechnology, Inc.
| ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE |
| IMSTEM BIOTECHNOLOGY, INC., XIAOFANG WANG and REN-HE XU |
| 22-1625 |
| April 12, 2022 |
| U.S. Court of Appeals, Federal Circuit |
| Patent Infringement (Fed. Qst.) |
Opinions
We have the following opinions for this case:
| Description |
|---|
| ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE v. IMSTEM BIOTECHNOLOGY, INC. |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 26, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 13 **TEXT ONLY** ORDER granting motion to extend time to file brief [ # 12 ] filed by Appellants ImStem Biotechnology, Inc., Xiaofang Wang and Ren-He Xu. The opening brief is due 06/27/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [852027] [JCW] [Entered: 05/26/2022 09:11 AM] |
| Filing 12 MOTION of Appellants ImStem Biotechnology, Inc., Xiaofang Wang and Ren-He Xu to extend the time to 06/27/2022 to file brief. Service: 05/25/2022 by email. [851950] [22-1625] [Sanford Weisburst] [Entered: 05/25/2022 04:56 PM] |
| Filing 11 Corrected Entry of appearance for Sanford Ian Weisburst; Sam Stephen Stake; Nicola R. Felice as counsel for Appellants ImStem Biotechnology, Inc., Xiaofang Wang and Ren-He Xu. Service: 04/26/2022 by email. [845551] [22-1625] [Sanford Weisburst] [Entered: 04/26/2022 04:05 PM] |
| Filing 10 NOTICE OF NON-COMPLIANCE: The submission of Appellants ImStem Biotechnology, Inc., Xiaofang Wang and Ren-He Xu, Entry of Appearance [ # 9 ], is not in compliance with the rules of this court (see attached). Compliant document due on 05/03/2022. Service as of this date by the Clerk of Court. [845355] [JCW] [Entered: 04/26/2022 08:44 AM] |
| Filing 9 Entry of appearance for Sanford I. Weisburst; Sam Stephen Stake; Nicola R. Felice as counsel for Appellants ImStem Biotechnology, Inc., Xiaofang Wang and Ren-He Xu. Service: 04/25/2022 by email. [845329] [22-1625] This document is non-compliant. See Doc No.[ # 10 ] [Sanford Weisburst] [Entered: 04/25/2022 08:40 PM] |
| Filing 8 Docketing Statement for the Appellants ImStem Biotechnology, Inc., Xiaofang Wang and Ren-He Xu. Service: 04/25/2022 by email. [845326] [22-1625] [Sanford Weisburst] [Entered: 04/25/2022 08:16 PM] |
| Filing 7 Certificate of Interest for Appellants ImStem Biotechnology, Inc., Xiaofang Wang and Ren-He Xu. Service: 04/25/2022 by email. [845324] [22-1625] [Sanford Weisburst] [Entered: 04/25/2022 08:11 PM] |
| Filing 6 Certificate of Interest for Cross-Appellant Astellas Institute for Regenerative Medicine. Service: 04/25/2022 by email. [845166] [22-1625] [David Frazier] [Entered: 04/25/2022 11:58 AM] |
| Filing 5 Docketing Statement for the Cross-Appellant Astellas Institute for Regenerative Medicine. Service: 04/25/2022 by email. [845161] [22-1625] [David Frazier] [Entered: 04/25/2022 11:54 AM] |
| Filing 4 Entry of appearance for David P. Frazier; Michael A. Morin; Rebecca L. Rabenstein; Brenda L. Danek; Yi Sun; Gabriel K. Bell as counsel for Cross-Appellant Astellas Institute for Regenerative Medicine. Service: 04/25/2022 by email. [845159] [22-1625] [David Frazier] [Entered: 04/25/2022 11:52 AM] |
| Filing 3 Official caption revised to reflect 22-1702 as cross-appeal. (see attached). Service as of this date by the Clerk of Court. [844312] [JCW] [Entered: 04/20/2022 01:01 PM] |
| Filing 2 Note to File: The following cases are consolidated: 22-1625 Lead with 22-1702 Cross-Appeal. The parties must file all documents in the lead appeal only. [844310] [22-1625, 22-1702] [JCW] [Entered: 04/20/2022 01:00 PM] |
| Filing 1 Appeal docketed. Received: 04/11/2022. [842581] Entry of Appearance is due on 04/26/2022. Certificate of Interest is due on 04/26/2022. Docketing Statement is due on 04/26/2022. Appellants' brief is due on 06/13/2022. [JCW] [Entered: 04/12/2022 11:47 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
